| Adjuvant Therapy . | Age <50 years . | Age >50 years . | Reference . | ||
|---|---|---|---|---|---|
| . | Recurrence . | Death . | Recurrence . | Death . | . |
| Combination chemotherapy versus no treatment | 37% SD 5 | 27% SD 6 | 22% SD 4 | 14% SD 5 | [19] |
| Recurrence* | Death* | ||||
| Tamoxifen** versus no treatment | 46% SD 4 | 22% SD 5 | [21] | ||
| Chemotherapy plus Tamoxifen** versus chemotherapy | 52% SD 8 | 47% SD 9 | [21] | ||
| Adjuvant Therapy . | Age <50 years . | Age >50 years . | Reference . | ||
|---|---|---|---|---|---|
| . | Recurrence . | Death . | Recurrence . | Death . | . |
| Combination chemotherapy versus no treatment | 37% SD 5 | 27% SD 6 | 22% SD 4 | 14% SD 5 | [19] |
| Recurrence* | Death* | ||||
| Tamoxifen** versus no treatment | 46% SD 4 | 22% SD 5 | [21] | ||
| Chemotherapy plus Tamoxifen** versus chemotherapy | 52% SD 8 | 47% SD 9 | [21] | ||
All data are presented as proportional risk reduction (percent and standard deviation [SD]).
*Regardless of age
**Tamoxifen 20 mg orally per day for five years (ER-positive patients only).
| Adjuvant Therapy . | Age <50 years . | Age >50 years . | Reference . | ||
|---|---|---|---|---|---|
| . | Recurrence . | Death . | Recurrence . | Death . | . |
| Combination chemotherapy versus no treatment | 37% SD 5 | 27% SD 6 | 22% SD 4 | 14% SD 5 | [19] |
| Recurrence* | Death* | ||||
| Tamoxifen** versus no treatment | 46% SD 4 | 22% SD 5 | [21] | ||
| Chemotherapy plus Tamoxifen** versus chemotherapy | 52% SD 8 | 47% SD 9 | [21] | ||
| Adjuvant Therapy . | Age <50 years . | Age >50 years . | Reference . | ||
|---|---|---|---|---|---|
| . | Recurrence . | Death . | Recurrence . | Death . | . |
| Combination chemotherapy versus no treatment | 37% SD 5 | 27% SD 6 | 22% SD 4 | 14% SD 5 | [19] |
| Recurrence* | Death* | ||||
| Tamoxifen** versus no treatment | 46% SD 4 | 22% SD 5 | [21] | ||
| Chemotherapy plus Tamoxifen** versus chemotherapy | 52% SD 8 | 47% SD 9 | [21] | ||
All data are presented as proportional risk reduction (percent and standard deviation [SD]).
*Regardless of age
**Tamoxifen 20 mg orally per day for five years (ER-positive patients only).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
